Breast Cancer Therapeutics in Major Developed Markets Is Expected to Grow at a Compound Annual Growth Rate (CAGR) of 5.1% to $13.1 Billion by 2020
GBI Research, the leading business intelligence provider, has released its latest research: 'Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs ', which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top five geographies in Europe (the UK, France, Germany, Spain and Italy) and Japan. The report provides an estimation of market size for 2013, along with...
View full press release